Brokerages Set U.S. Physical Therapy, Inc. (NYSE:USPH) Target Price at $114.00

Shares of U.S. Physical Therapy, Inc. (NYSE:USPH) have earned a consensus recommendation of “Buy” from the five analysts that are covering the firm, Marketbeat.com reports. Four research analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month target price among brokerages that have covered the stock in the last year is $114.00.

USPH has been the topic of a number of recent research reports. Citizens Jmp raised U.S. Physical Therapy to a “strong-buy” rating in a report on Monday, December 16th. JMP Securities began coverage on U.S. Physical Therapy in a report on Monday, December 16th. They issued an “outperform” rating and a $113.00 target price for the company. Barrington Research restated an “outperform” rating and set a $108.00 price objective on shares of U.S. Physical Therapy in a report on Thursday, November 21st. JPMorgan Chase & Co. upped their target price on U.S. Physical Therapy from $117.00 to $120.00 and gave the stock an “overweight” rating in a report on Tuesday, December 3rd. Finally, Bank of America raised U.S. Physical Therapy from a “neutral” rating to a “buy” rating and boosted their price target for the stock from $100.00 to $115.00 in a research report on Monday, December 16th.

U.S. Physical Therapy Price Performance

Shares of USPH opened at $87.40 on Thursday. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.27. The firm has a market cap of $1.32 billion, a PE ratio of 92.98, a P/E/G ratio of 3.61 and a beta of 1.48. The firm has a fifty day simple moving average of $90.81 and a two-hundred day simple moving average of $88.26. U.S. Physical Therapy has a 1-year low of $76.18 and a 1-year high of $113.63.

Insider Transactions at U.S. Physical Therapy

In related news, CFO Carey P. Hendrickson sold 516 shares of the business’s stock in a transaction on Monday, December 9th. The shares were sold at an average price of $96.25, for a total value of $49,665.00. Following the completion of the transaction, the chief financial officer now directly owns 20,469 shares in the company, valued at $1,970,141.25. The trade was a 2.46 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 1.70% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the company. Copeland Capital Management LLC boosted its stake in shares of U.S. Physical Therapy by 9.5% in the fourth quarter. Copeland Capital Management LLC now owns 839,356 shares of the company’s stock worth $74,459,000 after acquiring an additional 72,715 shares during the last quarter. State Street Corp boosted its stake in shares of U.S. Physical Therapy by 17.5% in the third quarter. State Street Corp now owns 667,868 shares of the company’s stock valued at $56,522,000 after purchasing an additional 99,244 shares during the period. Southernsun Asset Management LLC raised its stake in shares of U.S. Physical Therapy by 10.5% in the third quarter. Southernsun Asset Management LLC now owns 547,111 shares of the company’s stock valued at $46,302,000 after acquiring an additional 52,062 shares in the last quarter. Geode Capital Management LLC increased its stake in shares of U.S. Physical Therapy by 1.3% during the third quarter. Geode Capital Management LLC now owns 343,073 shares of the company’s stock worth $29,040,000 after buying an additional 4,477 shares during the period. Finally, Bahl & Gaynor Inc. increased its holdings in U.S. Physical Therapy by 135.4% in the fourth quarter. Bahl & Gaynor Inc. now owns 260,125 shares of the company’s stock valued at $23,076,000 after buying an additional 149,622 shares during the last quarter.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.